Foreign institutional investors (FIIs) bought Indian equities worth ₹4,240.39 crore on October 27, while domestic institutional investors (DIIs) were net sellers of ₹1,250.03 crore, according to provisional exchange data.
FIIs bought shares worth ₹24,517.65 crore and sold ₹20,277.26 crore during the session. DIIs purchased shares worth ₹15,702.74 crore and sold ₹16,952.77 crore.
The fund flow trend reversed from Monday, October 26, when FIIs were net sellers of Indian equities worth ₹1,462.49 crore, while DIIs bought shares worth ₹2,609.57 crore.
The Sensex ended 8 points lower at 73,599 on Tuesday, while the Nifty slipped 3.45 points to close at 22,750. The session remained volatile, with broader market indices outperforming the benchmarks.
The Nifty Bank index fell 392 points to 53,975, while the Nifty Midcap index rose 565 points to 57,030.
Among individual stocks, Tata Consumer Products was the top Nifty gainer, rising nearly 7% after reporting second-quarter results that were largely in line with expectations. APL Apollo Tubes gained more than 6% following positive management commentary, while Bharti Airtel rose over 3% after the release of September subscriber data by the Telecom Regulatory Authority of India (TRAI).
Capital market stocks extended their gains amid reports concerning long-term capital gains (LTCG) tax and securities transaction tax (STT), with BSE rising more than 2%.
IT stocks saw profit booking, while financial stocks remained under pressure. Mazagon Dock Shipbuilders fell over 6% following weak second-quarter results, while Sona BLW Precision Forgings gained 9%. Aegis Logistics declined more than 6% after its quarterly results.
Bajaj Auto ended more than 3% higher, while Maruti Suzuki gained 2% following their second-quarter results. Ather Energy extended its gains and was up 21% since announcing its results on Monday.
Cipla ended slightly lower after reporting largely in-line second-quarter results, with US sales coming in marginally below expectations. Apollo Hospitals and Max Healthcare retreated from their intraday highs in the final hour of trade amid developments in the drug-pricing case before the Supreme Court.
Also Read: Why journalists fear India’s data protection law could curb investigative reporting